M.D., Postdoctoral Fellow at Mayo Clinic, Chief Physician, Professor, and Master's Supervisor in the Department of Urology at Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine. Specializes in the early diagnosis of prostate cancer, minimally invasive surgery, and comprehensive treatment of intermediate to advanced prostate cancer. Received a doctoral degree from Shanghai Jiao Tong University, conducted postdoctoral research on prostate cancer at Mayo Clinic in the United States, and was a visiting scholar at the University Hospital of Montreal, Canada. Led three projects funded by the National Natural Science Foundation of China and five provincial or ministerial-level research projects. Published papers in renowned academic journals such as Nature Medicine, EMBO J, Theranostics, JU, and BJU, and participated in translating the prostate cancer chapters of the classic international urology textbook "Campbell-Walsh Urology." Invited multiple times to speak on prostate cancer topics at international conferences including the American Urological Association Annual Meeting, the International Urological Association Annual Meeting, and the Asian Urological Association Annual Meeting, among which important findings on the mechanisms of chemotherapy resistance in prostate cancer received the Best Paper Award at the 110th American Urological Association Annual Meeting. Has long been engaged in the clinical, research, and teaching work of prostate cancer, and specializes in various minimally invasive surgical treatments for prostate cancer, with long-term postoperative survival rates reaching internationally advanced levels. Prostate targeted biopsy using magnetic resonance/ultrasound fusion significantly improves the detection rate of early-stage prostate cancer. Has very rich experience in the standardized comprehensive treatment of intermediate to advanced prostate cancer, and proposed the concept of maximizing local treatment for bone metastatic prostate cancer, achieving outstanding therapeutic results, attracting patients from all over the country to seek treatment, and receiving widespread recognition.